News

thumbnail
Therapeutic Class
CSL dedicated to Hemgenix as it turns back on lenti-based gene therapiesCSL dedicated to Hemgenix as it turns back on lenti-based gene therapies

CSL Behring will deprioritize ex vivo lentiviral-based gene therapies and shutter a facility in California as it converges its advanced therapy R&D operations to Waltham, Massachusetts.

byDan Stanton
Nov 20, 2024
|
2 Min Read
thumbnail
Facilities & Capacity
Bavarian Nordic talks mpox manufacturing expansionBavarian Nordic talks mpox manufacturing expansion
byJosh Abbott
Nov 19, 2024
3 Min Read
thumbnail
Upstream & Downstream Processing
NIIMBL unveils antibody manufacturing action planNIIMBL unveils antibody manufacturing action plan
byJosh Abbott
Nov 19, 2024
2 Min Read
thumbnail
Facilities & Capacity
Lonza doubles bioconjugation capacity at Swiss facilityLonza doubles bioconjugation capacity at Swiss facility
byShreeyashi Ojha
Nov 16, 2024
2 Min Read
thumbnail
Facilities & Capacity
Cytiva strengthens APAC presence with Korea plantCytiva strengthens APAC presence with Korea plant
byShreeyashi Ojha
Nov 16, 2024
2 Min Read
thumbnail
Facilities & Capacity
Affinia and Forge team up to tackle cardiovascular diseasesAffinia and Forge team up to tackle cardiovascular diseases
byJosh Abbott
Nov 15, 2024
2 Min Read
Therapeutic Class
Repligen credits 10% revenue surge to new modalities and M&As
Repligen credits 10% revenue surge to new modalities and M&As
Nov 15, 2024
|
3 Min Read
byShreeyashi Ojha
Facilities & Capacity
From mundane to marvelous: The current and future uses of AI
From mundane to marvelous: The current and future uses of AI
Nov 13, 2024
|
4 Min Read
byJosh Abbott
Facilities & Capacity
IRA matches BIOSECURE in driving CDMO sector in India
IRA matches BIOSECURE in driving CDMO sector in India
Nov 13, 2024
|
4 Min Read
byDan Stanton
Facilities & Capacity
AstraZeneca pledges $3.5bn to biopharma research and manufacturing
AstraZeneca pledges $3.5bn to biopharma research and manufacturing
Nov 13, 2024
|
2 Min Read
byJosh Abbott
Therapeutic Class
Meitheal adds three biosimilars to US offering with new agreement
Meitheal adds three biosimilars to US offering with new agreement
Nov 13, 2024
|
2 Min Read
byJosh Abbott
Deal-Making
Novo taps Ascendis in $285m GLP-1 deal
Novo taps Ascendis in $285m GLP-1 deal
Nov 13, 2024
|
1 Min Read
byShreeyashi Ojha
Facilities & Capacity
AmplifyBio bolsters Ohio plant with $50m backing from Vitrian
AmplifyBio bolsters Ohio plant with $50m backing from Vitrian
Nov 12, 2024
|
1 Min Read
byShreeyashi Ojha
Webcasts
Talent dearth continues to puzzle life sciences industry, says recruitment expert
Talent dearth continues to puzzle life sciences, says recruitment expert
Nov 8, 2024
|
2 Min Read
byDan Stanton
Facilities & Capacity
Fujifilm launches manufacturing in Denmark following phase one expansion
Fujifilm launches manufacturing in Denmark following phase one expansion
Nov 8, 2024
|
2 Min Read
byJosh Abbott
Therapeutic Class
Post-pandemic dip: Panelists discuss CGT challenges
Post-pandemic dip: Panelists discuss CGT challenges
Nov 8, 2024
|
3 Min Read
byShreeyashi Ojha
Deal-Making
PE to buy CDMO Avid Bioservices for $1.1 billion
PE to buy CDMO Avid Bioservices for $1.1 billion
Nov 7, 2024
|
2 Min Read
byDan Stanton
Facilities & Capacity
Thermo Fisher expands India footprint with bioprocess design center
Thermo Fisher expands India footprint with bioprocess design center
Nov 7, 2024
|
3 Min Read
byShreeyashi Ojha
Facilities & Capacity
Sterling doubles ADC capacity at UK facility
Sterling doubles ADC capacity at UK facility
Nov 7, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Abzena expands QC testing at San Diego site
Abzena expands QC testing at San Diego site
Nov 6, 2024
|
1 Min Read
byJosh Abbott
Facilities & Capacity
Celltrion eyes expansion in light of extended Zymfentra access
Celltrion eyes expansion in light of extended Zymfentra access
Nov 6, 2024
|
2 Min Read
byJosh Abbott
Therapeutic Class
Artiva exec touts scalable NK cells to treat autoimmune diseases
Artiva exec touts scalable NK cells to treat autoimmune diseases
Nov 4, 2024
|
4 Min Read
byJosh Abbott
Facilities & Capacity
BIOSECURE: China’s loss could be India’s gain
BIOSECURE: China’s loss could be India’s gain
Nov 4, 2024
|
3 Min Read
byDan Stanton
Deal-Making
Chime partners with MedPacto for biologic manufacturing
Chime partners with MedPacto for biologic manufacturing
Nov 4, 2024
|
2 Min Read
byJosh Abbott
Therapeutic Class
High tides: Lilly’s $20bn spend, Amgen preps network to enter GLP-1 space
High tides: Lilly’s $20bn spend, Amgen preps network to enter GLP-1 space
Oct 31, 2024
|
3 Min Read
byDan Stanton
Upstream & Downstream Processing
School of Rockville: New biopharma training center welcomes students
School of Rockville: New biopharma training center welcomes students
Oct 30, 2024
|
3 Min Read
byJosh Abbott
Facilities & Capacity
Ardena bolsters bioanalytical capacity with Netherlands lab construction
Ardena bolsters bioanalytical capacity with Netherlands lab construction
Oct 30, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Q&A: Vetter SVP says sustainability is essential for long-term success
Q&A: Vetter SVP says sustainability is essential for long-term success
Oct 29, 2024
|
6 Min Read
byMillie Nelson, Josh Abbott
Facilities & Capacity
OmniaBio opens largest dedicated CGT CDMO facility in Canada
OmniaBio opens largest dedicated CGT CDMO facility in Canada
Oct 28, 2024
|
2 Min Read
byJosh Abbott
Facilities & Capacity
Rentschler bolsters production with 3,400 square-meter expansion
Rentschler bolsters production with 3,400 square-meter expansion
Oct 25, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
GSK to invest up to $800m in Pennsylvania site expansion
GSK to invest up to $800m in Pennsylvania site expansion
Oct 24, 2024
|
2 Min Read
byJosh Abbott
Upstream & Downstream Processing
Bioprocessing Q3: After 18 challenging months, is the worst behind?
Bioprocessing Q3: After 18 challenging months, is the worst behind?
Oct 24, 2024
|
4 Min Read
byDan Stanton
Facilities & Capacity
Governor unveils plans for $450m CGT innovation hub in New York
Governor unveils plans for $450m CGT innovation hub in New York
Oct 23, 2024
|
2 Min Read
byJosh Abbott
Regulations
Surviving BIOSECURE: US companies must prepare to avoid disruption
Surviving BIOSECURE: US companies must prepare to avoid disruption
Oct 23, 2024
|
3 Min Read
byJosh Abbott
Therapeutic Class
Investors prioritize efficacy in the CGT biz, experts say
Investors prioritize efficacy in the CGT biz, experts say
Oct 23, 2024
|
2 Min Read
byShreeyashi Ojha

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024